Relationships among acylation stimulating protein, adiponectin and complement C3 in lean vs obese type 2 diabetes.
about
Parainflammation, chronic inflammation, and age-related macular degenerationAssociation of adipocyte genes with ASP expression: a microarray analysis of subcutaneous and omental adipose tissue in morbidly obese subjects.Screening for potential serum-based proteomic biomarkers for human type 2 diabetes mellitus using MALDI-TOF MS.Relationship between obesity, adipocytokines and inflammatory markers in type 2 diabetes: relevance for cardiovascular risk preventionPlasma protein profiling reveals protein clusters related to BMI and insulin levels in middle-aged overweight subjectsPlasma adipokine and inflammatory marker concentrations are altered in obese, as opposed to non-obese, type 2 diabetes patients.Adipose tissue gene expression of factors related to lipid processing in obesity.Acylation stimulating protein, complement C3 and lipid metabolism in ketosis-prone diabetic subjects.Recombinant acylation stimulating protein administration to C3-/- mice increases insulin resistance via adipocyte inflammatory mechanisms.Proteomic analysis in type 2 diabetes patients before and after a very low calorie diet reveals potential disease state and intervention specific biomarkers.Deficiency of C5L2 increases macrophage infiltration and alters adipose tissue function in mice.Ethnic differences in acylation stimulating protein (ASP) in Xinjiang Uygur autonomous region, China.Rosiglitazone decreases postprandial production of acylation stimulating protein in type 2 diabetics.Acylation stimulating protein reduction precedes insulin sensitization after BPD-DS bariatric surgery in severely obese womenSerum Adipsin Levels throughout Normal Pregnancy and Preeclampsia.Type 2 diabetes and cardiovascular disease: getting to the fat of the matter.Effects of sugar-sweetened beverages on plasma acylation stimulating protein, leptin and adiponectin: relationships with metabolic outcomesLipoprotein lipase deficiency is associated with elevated acylation stimulating protein plasma levels.Elevated fetal adipsin/acylation-stimulating protein (ASP) in obese pregnancy: novel placental secretion via Hofbauer cells.Mice lacking C1q are protected from high fat diet-induced hepatic insulin resistance and impaired glucose homeostasis.Innate immune activation in obesity.Adipokines, oxidized low-density lipoprotein, and C-reactive protein levels in lean, overweight, and obese portuguese patients with type 2 diabetes.Low acylation stimulating protein levels are associated with cardiometabolic disorders-secondary to autoimmune activation?Association of C5L2 genetic polymorphisms with coronary artery disease in a Han population in Xinjiang, China.Acylation stimulating protein: a female lipogenic factor?Acylation-stimulating protein deficiency and altered adipose tissue in alternative complement pathway knockout mice.The role of complement system in adipose tissue-related inflammation.From compliment to insult: genetics of the complement system in physiology and disease in the human retina.Relationships among acylation-stimulating protein, insulin resistance, lipometabolism, and fetal growth in gestational diabetes mellitus women.Vertical Paper Analytical Devices Fabricated Using the Principles of Quilling and Kirigami.The C3a anaphylatoxin receptor is a key mediator of insulin resistance and functions by modulating adipose tissue macrophage infiltration and activation.Complement inhibition reduces injury in the type 2 diabetic heart following ischemia and reperfusion.A common genetic variant of FCN3/CD164L2 is associated with essential hypertension in a Chinese population.A model to study complement involvement in experimental retinal degeneration.
P2860
Q26796268-5BAD1401-15BC-4061-8530-354A16B07072Q30384917-4584FD9C-29F9-4D33-8B8E-7C908B0D3FEAQ30395380-87DC0493-F6D0-4BA5-A758-2BD9CFBCC52AQ33627732-69EA8566-1F65-4E4D-AA47-762829AED92DQ33784462-4B3CA7A1-CA7A-4AA0-A2BD-38E7D5A18140Q33868771-1FAC9F1E-F4CF-4C6E-962A-2F471492760AQ34037803-ED4ED664-AC44-4DBF-9FA5-04269683E3ACQ34282344-A09F0CE0-9676-456F-948D-AAE1EB4A0C21Q34442404-8177C76A-5154-4285-AF1B-4C6659EDDE91Q34557152-CEE4C80F-C95A-46C1-BD18-49BE24B491B2Q34695413-A202823D-688F-4E83-830D-535DB28E3149Q35481465-712182C7-2574-46AC-AA6D-886008162BA2Q35808559-A3349F2C-D9DD-44ED-9F00-19F6074AF9FCQ36203380-04AA4946-B715-4A89-9C39-553F3013BD92Q36527563-17D29457-0799-4543-8483-7B4316D0F33CQ36814772-C9E3A4E1-59F2-43F9-91BA-7B9735E7BB79Q37067258-CC6F268C-4450-43E3-BBFB-BD8E930CAB15Q37190372-BE234132-72AF-4D54-A923-4E7F7333393AQ37215478-B9A7E46F-FA10-4E80-BC47-40ABEEF6C18AQ37311913-5332D0C0-2BDF-4E6C-B0A8-3BE6EB0E07FEQ37466096-93942421-6F8C-4081-99BD-A9003971EE1EQ37515305-D1BC4CD0-BD2E-4299-87F1-012661D23486Q37680316-E5485A58-022B-41BF-AECD-5F9656FC1966Q37702759-8BFD3446-70B7-452C-A497-537BE6708EE7Q37846807-A424F569-0828-4E19-8E8E-8A8233B053A4Q38294970-16C9A67E-1C47-494E-ACB7-20D93E1ABEA5Q38692815-3566CE67-DED2-4810-84C0-80E7E0B2BB5EQ39290950-1B15D4E2-7C90-4C0E-96CD-36748415D469Q40896188-22213B5B-6B55-4F8B-94AC-B443714B93A4Q41244043-1F66BBAC-96E6-4D4E-93EE-7B020107D545Q42796229-BD108853-DCEF-4DF5-A496-C4C512B342F0Q46820263-0E0F750F-0E19-44BF-B6E0-029313BBC314Q47949871-0505E895-7D84-42FC-ABEB-CCD250A59881Q50046723-7F049B53-8FA0-4911-8DB7-EBCCFDD68BAE
P2860
Relationships among acylation stimulating protein, adiponectin and complement C3 in lean vs obese type 2 diabetes.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Relationships among acylation ...... lean vs obese type 2 diabetes.
@en
type
label
Relationships among acylation ...... lean vs obese type 2 diabetes.
@en
prefLabel
Relationships among acylation ...... lean vs obese type 2 diabetes.
@en
P2093
P2860
P356
P1476
Relationships among acylation ...... lean vs obese type 2 diabetes.
@en
P2093
K Cianflone
P2860
P2888
P304
P356
10.1038/SJ.IJO.0803173
P407
P577
2006-03-01T00:00:00Z
P5875
P6179
1023264254